Exact Sciences Acquires Preventiongenetics To Accelerate Availability Of Hereditary Cancer Testing For More Patients
Acquiring Company
Exact Sciences
Acquired Company
PreventionGenetics
Description
Exact Sciences Corp. (NASDAQ: EXAS) announced today it has acquired PreventionGenetics, a genetic testing laboratory, to complement its advanced cancer diagnostics portfolio and support its entrance into hereditary cancer testing (HCT). PreventionGenetics provides the clinical lab, expertise, and foundational technology necessary to accelerate the availability of HCT and help more patients know their germline risk of cancer and other diseases.
Quick answer
Exact Sciences is acquiring PreventionGenetics, announced January 10, 2022. Exact Sciences is based in Madison, Wisconsin, United States.
- How much did Exact Sciences pay for PreventionGenetics?
- The deal value was not disclosed.
- What does Exact Sciences do?
- Exact Sciences Corp. is a leading provider of cancer screening and diagnostic tests, known for its innovative solutions in early cancer detection.
- Where are Exact Sciences and PreventionGenetics based?
- Exact Sciences is based in Madison, Wisconsin, United States.
- Who are the decision-makers at Exact Sciences?
- Fundz holds 5 contacts at Exact Sciences. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Science And Engineering and Health Diagnostics
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Intellia Therapeutics Announces Acquisition Of Rewrite Therapeutics (February 3, 2022)
- Element Biosciences Closes Acquisition Of Loop Genomics (February 8, 2022)
- Labcorp Completes Acquisition Of Personal Genome Diagnostics (February 21, 2022)
- Medtronic To Acquire Affera (January 10, 2022)
- Co-Diagnostics, Inc. Announces Completion Of The Acquisition Of All Assets And Intellectual Property Related To At-Home/Point-Of-Care Platform (December 31, 2021)
- Blueprint Medicines Completes Acquisition Of Lengo Therapeutics (December 30, 2021)
Who to call at Exact Sciences, and when
When Exact Sciences changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Exact Sciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Exact Sciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Exact Sciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Exact Sciences makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired PreventionGenetics?
PreventionGenetics was acquired by Exact Sciences, based in Madison. The deal was reported on January 10, 2022. Exact Sciences Corp. is a leading provider of cancer screening and diagnostic tests, known for its innovative solutions in early cancer detection. Exact Sciences is privately held and operates in Information Technology.
When did Exact Sciences acquire PreventionGenetics?
Exact Sciences's acquisition of PreventionGenetics was reported on January 10, 2022. Exact Sciences Corp. (NASDAQ: EXAS) announced today it has acquired PreventionGenetics, a genetic testing laboratory, to complement its advanced cancer diagnostics portfolio and support its entrance into hereditary cancer testing (HCT). Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does PreventionGenetics do?
Founded in 2004 and located in Marshfield, Wisconsin, PreventionGenetics is a CLIA and ISO 15189:2012 accredited laboratory. It is privately held.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.